Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
27. January 2023 • News
27. January 2023 • News
Think ‘Shark Tank’ for the medical industry: #kiddingnotkidding. But when 16 international teams presented their best ideas for medical devices and digital health solutions at MEDICAL FORGE Leipzig’s selection day in December 2022, there was some anticipation in the room. After the accelerator’s successful start in 2022 with 8 contenders, the number of applicants for this second round had tripled and spanned the globe – from Kazakhstan to the USA. A jury of Leipzig-based medical experts chose 8 top teams for 2023. Starting in April, these winning start-ups can look forward not only to state-of-the-art infrastructure (think fully-equipped wet labs and workstations), but to helpful coaching and access to Leipzig’s innovation ecosystem. The ultimate goal: To change lives through innovative medical technology.
For more details, please go to medicalforge.de
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
The European Commission has approved the Saxon ERDF/JTF program for the funding period 2021 to 2027.